Toxicity
Showing 9976 - 10000 of >10,000
Hepatitis B, Chronic, Hepatitis D Trial in Chisinau, Kyiv (ATI-2173, Viread, AB-729)
Terminated
- Hepatitis B, Chronic
- Hepatitis D
- ATI-2173
- +2 more
-
Chisinau, Republic Of Moldova, Moldova, Republic of
- +1 more
Nov 15, 2022
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +15 more
- trebananib
- +3 more
-
Buffalo, New York
- +1 more
Sep 8, 2022
Malignant Mesothelioma Trial in United States (pemetrexed disodium, clinical observation)
Completed
- Malignant Mesothelioma
- pemetrexed disodium
- clinical observation
-
Scottsdale, Arizona
- +144 more
Aug 16, 2021
Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle
Completed
- Adult Alveolar Soft Part Sarcoma
- +18 more
- Gemcitabine
- +5 more
-
Portland, Oregon
- +1 more
Sep 23, 2021
Polymyositis, Dermatomyositis Trial in Seoul (PN-101)
Enrolling by invitation
- Polymyositis
- Dermatomyositis
- PN-101
-
Seoul, Korea, Republic of
- +2 more
Jun 10, 2022
Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)
Not yet recruiting
- Metastatic Breast Cancer
- Breast Cancer
-
Houston, TexasM D Anderson Cancer Center
Feb 16, 2022
Vascular Thrombus Involvement in Nephroblastoma
Not yet recruiting
- Nephroblastoma With Vena Cava Thrombosis
-
Le Kremlin Bicêtre, France
- +1 more
Jan 4, 2022
Metastatic Breast Cancer Trial in Worldwide (Trastuzumab Emtansine, Atezolizumab, Placebo)
Recruiting
- Metastatic Breast Cancer
- Trastuzumab Emtansine
- +2 more
-
Fountain Valley, California
- +139 more
Aug 17, 2022
Lung Cancer Trial in Pittsburgh (Sulforaphane, Placebo)
Recruiting
- Lung Cancer
- Sulforaphane
- Placebo
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Dec 6, 2021
Renal Transplant Rejection Trial in Los Angeles (Belatacept)
Completed
- Renal Transplant Rejection
-
Los Angeles, CaliforniaUCLA Kidney Transplant Research
Apr 21, 2021
Muscle Invasive Bladder Cancer Trial in New York, Shanghai (APL-1202 in combination with tislelizumab, Tislelizumab alone)
Recruiting
- Muscle Invasive Bladder Cancer
- APL-1202 in combination with tislelizumab
- Tislelizumab alone
-
New York, New York
- +1 more
Feb 21, 2022
Gastrointestinal Cancer Trial in Philadelphia ('Penny' via Memora Platform)
Recruiting
- Gastrointestinal Cancer
- 'Penny' via Memora Platform
-
Philadelphia, PennsylvaniaAbramson Cancer Center
Dec 16, 2022
Malignant Tumor of Breast Trial in Clermont-Ferrand, Paris, Vandoeuvre les Nancy (Saline, Ropivacaine)
Completed
- Malignant Neoplasm of Breast
-
Clermont-Ferrand, France
- +3 more
Feb 15, 2022
Lymphoma, Large B-Cell, Diffuse Trial in Austria (Venetoclax, Obinutuzumab)
Completed
- Lymphoma, Large B-Cell, Diffuse
-
Graz, Austria
- +5 more
Feb 15, 2022
Recurrent Primary Amyloidosis Trial in United States (drug, biological, other)
Active, not recruiting
- Recurrent Primary Amyloidosis
- Cyclophosphamide
- +5 more
-
Duarte, California
- +4 more
Mar 10, 2021
Urinary Tract Infections Trial in Youngstown (Gentamicin, Standard of Care)
Recruiting
- Urinary Tract Infections
- Gentamicin
- Standard of Care
-
Youngstown, OhioSt. Elizabeth Youngstown Hospital
Jan 18, 2023
Ovarian Cancer Trial in Worldwide (Paclitaxel + Carboplatin every 3 weeks, Carboplatin monotherapy every 3 weeks, Weekly
Completed
- Ovarian Cancer
- Paclitaxel + Carboplatin every 3 weeks
- +2 more
-
Montréal, Canada
- +62 more
Aug 3, 2020
Invasive Breast Cancer, Chemotherapeutic Toxicity, Myalgia Trial (Gabapentin 300mg)
Unknown status
- Invasive Breast Cancer
- +3 more
- Gabapentin 300mg
- (no location specified)
Jun 12, 2018
Soft Tissue Sarcomas Trial in Groningen, Leiden, Nijmegen (pre-operative radiotherapy)
Recruiting
- Soft Tissue Sarcomas
- pre-operative radiotherapy
-
Groningen, Netherlands
- +2 more
Aug 3, 2021
Acute Promyelocytic Leukemia Trial in Canada, United States (Tretinoin and Arsenic Trioxide)
Completed
- Acute Promyelocytic Leukemia
- Tretinoin and Arsenic Trioxide
-
Los Angeles, California
- +11 more
Nov 2, 2021
NSCLC, Stage III Trial in Pavia (Durvalumab)
Recruiting
- NSCLC, Stage III
-
Pavia, ItalyFondazione IRCCS Policlinico San Matteo
Nov 9, 2021
Pancreatic Carcinoma Trial in Hangzhou (TQB2858 injection, Anlotinib Hydrochloride Capsule, Gemcitabine HCl for injection)
Not yet recruiting
- Pancreatic Carcinoma
- TQB2858 injection
- +3 more
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of Med
Jan 14, 2022
Patients With SLE Using OCT and OCTA
Recruiting
- SLE (Systemic Lupus)
- Optvue OCT
-
Minya, EgyptMinia university hospital
Jul 5, 2021